NP / PA
Planned Parenthood of Greater Washington and North Idaho
Planned Parenthood of Greater Washington and North Idaho was paid $2.51M by Medicaid between Jan 2018 and Dec 2024, across 27 billing codes. Its largest line is S9430, Pharmacy compounding and dispensing services — 30% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD OF GREATER WASHINGTON AND NORTH IDAHO
BELLINGHAM, WA 98225
BELLINGHAM, WA 98225
33aNPI1790902906assigned 04/19/2007
33bProvider typeWomen's Health Nurse Practitioner
28Total paid$2.51M
24GClaims67,772
24DCodes billed27
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,141 | $399K | |
| 2019 | 9,211 | $316K | |
| 2020 | 9,485 | $279K | |
| 2021 | 9,706 | $292K | |
| 2022 | 11,185 | $468K | |
| 2023 | 10,574 | $446K | |
| 2024incomplete | 6,470 | $309K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S9430 | Pharmacy compounding and dispensing services | 30% | 12,738 | 10,948 | $742K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 9,274 | 8,754 | $599K |
| S4993 | Contraceptive pills for birth control | 8.0% | 11,630 | 9,379 | $201K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 5.2% | 1,254 | 1,216 | $129K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.8% | 899 | 851 | $121K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.7% | 935 | 903 | $117K |
| 81025 | 4.2% | 8,158 | 7,768 | $106K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.6% | 1,837 | 1,768 | $91K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.2% | 1,094 | 1,071 | $81K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2.4% | 4,286 | 4,076 | $61K |
| 58300 | 2.2% | 163 | 158 | $56K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.5% | 1,102 | 1,079 | $38K |
15 more codes
| 86703 | 1.3% | 2,812 | $33K | |
| 36415 | Collection of venous blood by venipuncture | 1.3% | 2,813 | $32K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 95 | $19K |
| 99385 | <1% | 199 | $18K | |
| 87210 | <1% | 3,488 | $17K | |
| 36416 | <1% | 2,310 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,221 | $12K |
| J3490 | Unclassified drugs | <1% | 1,248 | $8K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 15 | $6K |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | <1% | 40 | $4K |
| 11981 | <1% | 15 | $3K | |
| 58301 | <1% | 40 | $2K | |
| 81002 | <1% | 53 | $147.60 | |
| 85018 | <1% | 29 | $51.11 | |
| A4550 | Surgical trays | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialACEVES, SENDI (COO)